Consensus Forecasts

June 2010

Consensus compiled by Syngenta from forecasts by 23 analysts.


2010

$ High Mean Low
Sales 12'190m 11'532m 11'059m
EBITDA* 2'877m 2'664m 2'403m
Net Income* 1'778m 1'609m 1'469m
Earnings per share (EPS)** 19.08 17.25 15.93

2011

$ High Mean Low
Sales 13'012m 12'161m 11'589m
EBITDA* 3'167m 2'888m 2'515m
Net Income* 1'962m 1'784m 1'527m
Earnings per share (EPS)** 21.12 19.20 15.90

2010 Syngenta Outlook

In the second half of 2010 we expect positive volume momentum to continue. As we approach the main season in Latin America, we are assuming that the current favorable fundamentals will support further growth in our business there. This, coupled with careful control of costs and increasing profitability in Seeds, should allow us to achieve full year operating income* around last year’s level. We will also target a return on invested capital exceeding 20%.

* excluding restructuring & impairment
** EPS on a fully-diluted basis, excluding restructuring and impairment


Target Share Price

CHF High Mean Low
  365 314 250

Analysts Covering Syngenta

The following list*** includes institutions that publish regular research reports on Syngenta. Their reports have been used to create the consensus forecast included above.

Institution Analyst
Bank am Bellevue Bruno Eschli
Bank of America Merrill Lynch Andrew Stott
BZ Bank Aktiengesellschaft Nils Engel
CACheuvreux Martin Roediger
Citigroup Andrew Benson
Credit Suisse Rhian Tucker
Deutsche Bank Virginie Boucher-Ferte
DZ Bank Heinz Müller
Exane BNP Paribas Rim Bennani
Gilford Securities Paul Christopherson
Goldman Sachs Richard Logan
Helvea Martin Flückiger
J.P. Morgan Neil Tyler, Martin Evans
Kepler Capital Markets Florian Gaiser
Main First Bank AG Ronald Köhler
Morgan Stanley Paul Walsh
Nomura Jean De Watteville
NZB Neue Zürcher Bank Bernd Pomrehn
Redburn Partners Tony Jones
Soleil Securities Group Mark Gulley
UBS Thomas Gilbert
UniCredit MIB (HVB) Andreas Heine
Vontobel Patrick Rafaisz

*** The above list is a selection of analysts currently covering Syngenta. We do not make any claim that this list is comprehensive of all institutions publishing regular research reports on Syngenta.

Any opinions, forecasts, estimates, projections or predictions regarding Syngenta's performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Syngenta. By providing these names, Syngenta does not imply its endorsement of or concurrence with their reports, conclusions or recommendations and Syngenta does not assume any liability for the accuracy of the information.

Please note that this list does not constitute a solicitation to buy, hold or sell securities.

© 2010 Syngenta